Publications by authors named "M Akahoshi"

Claim this Profile
C
Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.
Masahiro Ayano, Naoyasu Ueda, Koji Mishima, Shun-Ichiro Ota, Kazuo Kushimoto, Mitsuteru Akahoshi

Joint Bone Spine· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult-onset Still's disease following COVID-19: a case report and literature review.
Tsubasa Maeda, Goshi Komine, Ryosuke Noda, Mikiya Komatsu, Mariko Sakai, Mitsuteru Akahoshi

Mod Rheumatol Case Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated soluble CD226 in Takayasu arteritis is useful for differentiation from giant cell arteritis, disease activity assessment, and prognosis prediction.
Miki Nakano, Masahiro Ayano, Shoichi Fukui, Nozomi Iwanaga, Tomofumi Tatsutani, Mitsuteru Akahoshi

Medicine (Baltimore)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment selection in the clinical practice of systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.
Masahiro Ayano, Naoyasu Ueda, Koji Mishima, Shun-Ichiro Ota, Kazuo Kushimoto, Mitsuteru Akahoshi

Mod Rheumatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cluster analysis defines four groups of Japanese patients with adult-onset Still's disease.
Yuri Shirahama, Ayako Kokuzawa, Yusuke Yamauchi, Yohei Kirino, Hideto Nagai, Mitsuteru Akahoshi

Mod Rheumatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis